Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-04-03Clinical Trial Update: Using Multimedia Technology for Hypertension Control for Low-Income African Americans [NA]
This clinical trial update describes a study evaluating the use of multimedia technology to improve hypertension control among low-income Af…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Factorial Study of Metoprolol Succinate TOPROL-XL (324A) [Phase 3]
Phase 3 factorial study of metoprolol succinate (TOPROL-XL) for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension [Phase 4]
Phase 4 clinical trial updating on the efficacy and safety of metoprolol succinate prolonged-release tablet in patients with mild to moderat…
-
FDA approval · 2009-03-12FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals' amlodipine besylate (generic) product, signaling regulatory approval for t…
-
FDA approval · 2009-03-12FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC, resulting in updated labeling for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-03-03Clinical Trial Update: Olmesartan on Ambulatory Blood Pressure Change
Clinical trial update examining olmesartan's effect on ambulatory blood pressure in hypertension; sponsor is National Taiwan University Hosp…
-
CLINICAL_TRIALS trial_result · 2009-02-27Clinical Trial Update: The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis [Phase 4]
Phase 4 clinical trial evaluating eight-polar bioelectrical impedance analysis to optimize blood pressure control and fluid status; the stud…
-
FDA approval · 2009-02-26FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited, confirming regulatory clearance for the gener…
-
FDA approval · 2009-02-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Spironolactone submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2009-02-20FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for furosemide from Solco Healthcare LLC, adding a new manufacturing source for the product.
-
FDA approval · 2009-02-19FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited, resulting in approval of a generic Atenolol produc…
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Acute Hemodynamic Effects of Cocoa Polyphenols in Subjects With Hypertension and Optimal Blood Pressure [Phase 1]
A Phase 1 study evaluated the acute hemodynamic effects of cocoa polyphenols in adults with hypertension and optimal blood pressure; the tri…
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria [Phase 4]
Phase 4 trial evaluating specific blockade of angiotensin II to reduce podocyturia in glomerular nephropathies with hypertension and protein…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria [Phase 4]
Phase 4 crossover trial evaluating Hexalacton in patients with Type 1 diabetes mellitus and diabetic nephropathy; the current status of the …
-
CLINICAL_TRIALS trial_result · 2009-02-10Clinical Trial Update: Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults [Phase 4]
Phase 4 trial comparing valsartan/hydrochlorothiazide combination versus hydrochlorothiazide alone in obese adults with hypertension to asse…
-
FDA approval · 2009-02-06FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: Evaluation of Atacand® (Candesartan) in Daily Medical Practice
The document reports the completion of a clinical trial evaluating candesartan (Atacand) for hypertension in daily medical practice.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Efficacy and Safety of Moxonidine in Indian Patients [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of moxonidine in Indian patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension [Phase 2]
A completed Phase 2 clinical trial evaluating the efficacy and safety of SLV306 in patients with hypertension.
-
FDA approval · 2009-01-30FDA Approved: AMILORIDE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approves Sigmapharm Laboratories, LLC's amiloride hydrochloride as an original generic application (ANDA) product space.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [NA]
A completed clinical trial comparing eprosartan/hydrochlorothiazide to enalapril/hydrochlorothiazide in hypertensive patients with type 2 di…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment [Phase 2]
This Phase 2 clinical trial update assesses the prevalence of sleep apnea in patients with refractory hypertension and examines the effect o…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage [Phase 4]
Phase 4 study evaluating the efficacy and safety of fixed-dose valsartan/hydrochlorothiazide in patients with slight hypertension and target…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study
The IMPULSION study, a trial examining the implementation of guidelines for managing arterial hypertension, has completed.
-
FDA approval · 2009-01-22FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lotensin (benazepril hydrochloride) from Validus Pharmaceuticals LLC. The action is a supple…